Elanco Animal Health: Q3 Earnings Insights

Shares of Elanco Animal Health ELAN rose 0.1% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were down 56.67% year over year to $0.13, which beat the estimate of $0.12.

Revenue of $889,600,000 up by 15.34% year over year, which missed the estimate of $909,340,000.

Outlook

Earnings guidance hasn't been issued by the company for now.

Elanco Animal Health hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Nov 06, 2020

Time: 08:00 AM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Finvestor.elanco.com%2F&eventid=2633313&sessionid=1&key=EA8184751BD8A6CEA871F72CB5978101&regTag=&sourcepage=register

Technicals

Company's 52-week high was at $34.09

Company's 52-week low was at $15.17

Price action over last quarter: Up 38.09%

Company Description

Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Latin America, and the Asia Pacific with the highest revenue from the North America segment. It offers a range of food animal products used in cattle, sheep, goats, and swine production.